Department of pharmaceutical outcomes and policy welcomes Dr. Serena Guo as newest faculty member

The Department of pharmaceutical outcomes and policy welcomes Jingchuan “Serena” Guo, Ph.D., M.D., M.P.H., as a new assistant professor. Guo’s  research is built at the intersection of epidemiology, and pharmaceutical health services and outcome research, with a focus on diabetes and cardiorenal outcomes. She uses large healthcare databases and advanced analytics (e.g., machine learning) to study the delivery of high-quality care, the effectiveness and safety of treatment and interventions, and the predictions of health outcomes.